Does Parkinson’s disease start in the gut? Arthur LionnetLaurène Leclair-VisonneauThomas G. Beach Review 16 October 2017 Pages: 1 - 12
Parkinson’s disease: experimental models and reality Peizhou JiangDennis W. Dickson Review 18 November 2017 Pages: 13 - 32
Multiple system atrophy: experimental models and reality Cassia OverkEdward RockensteinEliezer Masliah Review 20 October 2017 Pages: 33 - 47
MSA prions exhibit remarkable stability and resistance to inactivation Amanda L. WoermanSabeen A. KazmiStanley B. Prusiner Original Paper 28 August 2017 Pages: 49 - 63
Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term Nolwen L. ReySonia GeorgePatrik Brundin Original Paper Open access 05 December 2017 Pages: 65 - 83
Polygenic hazard score: an enrichment marker for Alzheimer’s associated amyloid and tau deposition Chin Hong TanChun Chieh FanFor the Alzheimer’s Disease Neuroimaging Initiative Original Paper 24 November 2017 Pages: 85 - 93
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy Georg von JonquieresZiggy H. T. SpencerMatthias Klugmann Original Paper Open access 07 November 2017 Pages: 95 - 113
Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours Thomas J. StoneAngus KeeleyThomas S. Jacques Original Paper Open access 20 October 2017 Pages: 115 - 129
A knock-in/knock-out mouse model of HSPB8-associated distal hereditary motor neuropathy and myopathy reveals toxic gain-of-function of mutant Hspb8 Delphine BouhyManisha JunejaVincent Timmerman Original Paper Open access 05 August 2017 Pages: 131 - 148
CASQ1 mutations impair calsequestrin polymerization and cause tubular aggregate myopathy Johann BöhmXavière LornageJocelyn Laporte Correspondence 16 October 2017 Pages: 149 - 151
Regional levels of physiological α-synuclein are directly associated with Lewy body pathology Daniel ErskineLina PattersonChristopher M. Morris Correspondence 13 November 2017 Pages: 153 - 154
Accumulation of dysfunctional SOD1 protein in Parkinson’s disease is not associated with mutations in the SOD1 gene Benjamin G. TristJennifer A. FifitaKay L. Double Correspondence 19 October 2017 Pages: 155 - 156
Phenotyping cognitive impairment in dialysis patients: insights from experimental mouse models Dearbhla M. Kelly Correspondence 20 October 2017 Pages: 157 - 158